Showing results (231-240 of 262) with videos related to

Sort By:
Pageof 27
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 16, 2025
Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing ColectomyCharlotte Larson, Jeffrey A Berinstein, Nicholas Tedesco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2020
Coronavirus Disease 2019 (COVID-19) Clinical Trial Oversight at a Major Academic Medical Center: Approach of Michigan MedicineKayte Spector-Bagdady, Peter D R Higgins, Keith D Aaronson, et al.
The Lancet. Gastroenterology & Hepatology|September 8, 2023
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance studySéverine Vermeire, Silvio Danese, Wen Zhou, et al.
Gastroenterology|November 8, 2021
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's DiseaseBruce E Sands, Laurent Peyrin-Biroulet, Jaroslaw Kierkus, et al.
The American Journal of Pathology|February 15, 2015
Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosisThomas H Sisson, Iyabode O Ajayi, Natalya Subbotina, et al.
Inflammatory Bowel Diseases|November 18, 2021
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's DiseaseJurij Hanzel, Vipul Jairath, Peter De Cruz, et al.
Inflammatory Bowel Diseases|May 13, 2024
MRI and Blood-based Biomarkers Are Associated With Surgery in Children and Adults With Ileal Crohn's DiseaseJonathan R Dillman, Jean A Tkach, Joel G Fletcher, et al.
The American Journal of Gastroenterology|January 9, 2013
Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial dataB Joseph Elmunzer, Peter D R Higgins, Sameer D Saini, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2023
Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitisRemo Panaccione, Silvio Danese, Wen Zhou, et al.
Gastroenterology|April 10, 2017
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a StudyBruce E Sands, Jingjing Chen, Brian G Feagan, et al.
Pageof 27